Hardy Reed’s LeMaitre Vascular LMAT Stock Holding History

Hardy Reed’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Buy	+2,325	New	+$222K	0.02%	212

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hardy Reed's LMAT Position: Q1 2026 in Review

Hardy Reed opened a new position in LeMaitre Vascular (LMAT) in Q1 2026: 2,325 shares worth $254K. The stake represents 0.02% of the portfolio and ranks #212 among its holdings.

339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Hardy Reed held 2,325 shares of LeMaitre Vascular worth $254K as of Q1 2026.
LeMaitre Vascular was a new Hardy Reed position in Q1 2026.
LeMaitre Vascular made up 0.02% of Hardy Reed's portfolio in Q1 2026, its #212 holding.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.